Diabetes clinic taps DarioHealth for blood glucose monitoring tech

DarioHealth (NSDQ:DRIO) has partnered with the Diabetes and Endocrinology Consultants of Pennsylvania to bring its blood glucose monitoring system to the 5,000-patient facility.

The company’s blood glucose monitor, which syncs with Dario’s diabetes management app, connects via a headphone jack to a mobile device, helping diabetes patients monitor their blood glucose throughout the day. The app also records carbohydrate intake, insulin use and physical activity.

“When I showed my patients how to use Dario, they immediately got it and I realized that this was going to be a game-changing device,” Dr. Alan Shorr said in prepared remarks.

“The Dario system provides patients with a platform to control their blood sugars in an easy and concise manner. The patient’s sugars and essential data is easy to understand, and patients are coming to the office more informed. My team is able to interpret the data and teach our patients to improve their control of diabetes. This is done in part because Dario simplifies the complexity of diabetes treatment and improves the quality of life for my patients. The device is easy to maintain and does not require carrying multiple items, which is a major plus.”

“We are excited that Dario technology will help us seamlessly incorporate remote blood glucose monitoring into our daily clinical processes, thereby allowing us to actively identify and manage those patients with diabetes that need our guidance in a timely manner,” Dr. Arvind Cavale added. “We hope to demonstrate with this project that clinicians and technology companies can bring high-value services to the management of chronic illnesses such as diabetes.”

“It’s very encouraging to hear from endocrinologists that people with diabetes can get better care with Dario,” DarioHealth chairman & CEO Erez Raphael said. “This is an important step in DarioHealth’s growth and market penetration as we are planning to reach additional users through key opinion leaders and clinics. Partnering with such clinics will allow us to reach users in a faster and a more efficient manner.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW